Results 201 to 210 of about 53,618 (254)

Multi-Omic Profiling of Gut Microbiota and Fecal Metabolites in Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study. [PDF]

Health Sci Rep
Li YM, He FF, Donge-Liu, Bin-Xu, Shuyi-Li.   +4 more
europepmc   +1 more source

Association between bisphenol exposure and polycystic ovary syndrome risk: an integrated systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Gui Z, Lin H, Wang C, Yao Y.
europepmc   +1 more source

Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases. [PDF]

Front Endocrinol (Lausanne)
Li B, Li Y, Li X, Yu Z, Yu J, Shao Y, Li T, Sun S, Zhou L, Yao R, Cheng W, Zhu J, Miao J, Li Y, Wu Y, Shi Y, Zhou J, Yu C, Ling C.   +18 more
europepmc   +1 more source

Natural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential. [PDF]

Int J Mol Sci
Linares R, Rosas G, Vieyra E, Chaparro A, Espinoza JA, Ramírez DLA, Silva CC, Rosas P, Macías VM, Morales-Ledesma L.   +9 more
europepmc   +1 more source

Cell type–resolved transcriptomic map of skeletal muscle in women with polycystic ovary syndrome

Stener-Victorin E, Sparovec TG, Eriksson G, Schutten R, Li C, Lu H, Rosa J, Dahmani S, Torstensson S, Ohlsson C, Lindgren E, Damdimopoulou P, Hirschberg AL, Deng Q, Lindskog C.   +14 more
europepmc   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Polycystic ovaries

The British Journal of Radiology, 2002
Transvaginal ultrasound is currently the gold standard for diagnosing polycystic ovaries. The results of studies using ultrasound suggest a prevalence in young women of at least 20%. Between 5% and 10% of these women with polycystic ovaries shown on ultrasound will have the classical symptoms of polycystic ovary syndrome such as infertility ...
K, Lakhani, A M, Seifalian, W U, Atiomo, P, Hardiman   +3 more
openaire   +2 more sources

Polycystic Ovary Syndrome

Obstetrics & Gynecology, 2004
Women with polycystic ovarian syndrome have chronic anovulation and androgen excess not attributable to another cause. This condition occurs in approximately 4% of women. The fundamental pathophysiologic defect is unknown, but important characteristics include insulin resistance, hyperandrogenism, and altered gonadotropin dynamics.
Ertug Kovanci, John E. Buster
  +6 more sources

The androgenic polycystic ovary

American Journal of Obstetrics and Gynecology, 1976
The polycystic ovary has the capacity to produce excessive androgens (delta4-androstenedione, dehydroepiandrosterone, and testosterone). Whether this disorder is caused by constant pituitary priming of the ovaries due to hypothalamic-pituitary derangement or an ovarian enzyme defect, the end result is the same, i.e., abnormal androgen production. In an
R B, Greenblatt, V B, Mahesh
openaire   +2 more sources

Polycystic ovary syndrome

Journal of Pediatric and Adolescent Gynecology, 2003
Polycystic ovary syndrome (PCOS) is classically thought of as the triad of oligo/amenorrhea hirsutism and obesity. However it has become apparent that this disorder is heterogeneous and many subtypes exist. The basic abnormality relates to overproduction of androgens primarily from the ovary leading to the symptoms of menstrual dysfunction and ...
openaire   +3 more sources